Arcadia Biosciences Stock Under $1: Why RKDA’s Next Move Hinges on Zola and Cash
Arcadia Biosciences Inc. shares were quoted higher but still below $1 early Thursday, leaving the micro-cap wellness-products company in a narrow market lane where small changes in cash, sales or financing can move the stock. Micro-cap means a company with a very small market value; Arcadia’s was about $1.9 million at the latest quote. Why it matters now: there was no newer operating release on Arcadia’s investor-relations feed after its May 14 results, and the latest listed company filing was May 15. That puts the focus back on what the last filing cycle showed — Zola coconut water growth on one side, funding pressure on the other.